Your browser doesn't support javascript.
loading
The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma.
Pessoa, Rodrigo Rodrigues; Nabavizadeh, Reza; Quevedo, Fernando; Joyce, Daniel D; Lohse, Christine M; Sharma, Vidit; Costello, Brian A; Boorjian, Stephen A; Thompson, R Houston; Leibovich, Bradley C; Cheville, John C.
Afiliação
  • Pessoa RR; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Nabavizadeh R; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Quevedo F; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Joyce DD; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Lohse CM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Sharma V; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Costello BA; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Thompson RH; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Leibovich BC; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Cheville JC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
J Urol ; 210(4): 611-618, 2023 10.
Article em En | MEDLINE | ID: mdl-37338930
ABSTRACT

PURPOSE:

Multiple prognostic models exist to assess survival among patients with metastatic clear cell renal cell carcinoma. However, the relative contribution of histopathological features of the metastasis has not been extensively studied. Herein, we compared models using clinical, primary tumor, and metastatic features to predict cancer-specific survival for patients with surgically resected metastatic clear cell renal cell carcinoma. MATERIALS AND

METHODS:

We studied 266 patients who had undergone nephrectomy between 1970 and 2019, and who had a single site of metastasis completely resected. Two versions of the metastatic clear cell renal cell carcinoma score published by Leibovich et al were calculated, using grade and necrosis from the primary tumor and using grade and necrosis from the metastasis. Predictive abilities of these 2 versions and a third model that included metastatic features only were compared using c-indexes from Cox proportional hazards models.

RESULTS:

A total of 197 patients died from renal cell carcinoma at a median of 2.3 years (IQR 1.1-4.5); median follow-up among survivors was 13.2 years (IQR 10.0-14.5). The Leibovich score using grade and necrosis from the metastasis (c=0.679) had similar predictive ability compared to the original Leibovich score using grade and necrosis from the primary tumor (c=0.675). A third model (c=0.707) demonstrated that metastasectomy within 2 years after nephrectomy, presence of bone metastasis, high grade, and sarcomatoid differentiation in the metastasis were significantly associated with cancer-specific survival.

CONCLUSIONS:

Scoring algorithms calculated using histopathological features of the metastasis can be used to predict cancer-specific survival for patients with surgically resected metastatic clear cell renal cell carcinoma. These findings are of particular importance for instances when primary tumor histopathology is not readily available.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Urol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Urol Ano de publicação: 2023 Tipo de documento: Article